SEC Form 4 · accession 0001493152-26-041290
EXOZYMES INC. · EXOZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Heltzen
Officer — Chief Executive Officer
Period of report
Aug 19, 2026
Accepted (ET)
Sep 2, 2026 · 7:33 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002010788
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 26, 2026 | P | 4 | $7.58 | A | 14,708 | D | |
| Common Stock | Aug 26, 2026 | P | 251 | $7.35 | A | 14,704 | D | |
| Common Stock | Aug 26, 2026 | P | 250 | $7.60 | A | 14,453 | D | |
| Common Stock | Aug 25, 2026 | P | 250 | $7.52 | A | 14,203 | D | |
| Common Stock | Aug 25, 2026 | P | 100 | $7.50 | A | 13,953 | D | |
| Common Stock | Aug 19, 2026 | A | 8,841 | $6.40 | A | 13,853 | D |
Table II — derivative securities
No Table II lines on this filing.